pirinixic acid has been researched along with Liver Cirrhosis in 3 studies
pirinixic acid: structure
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We tested this hypothesis using rat thioacetamide (TAA) models of liver cirrhosis." | 3.72 | PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. ( Harano, Y; Itoh, Y; Kirishima, T; Minami, M; Morita, A; Nakamura, H; Okanoue, T; Toyama, T; Yamauchi, N, 2004) |
| "However, its role in alcoholic liver fibrosis has not been fully clarified." | 1.39 | Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice. ( Di, HL; Du, JH; Kong, LB; Li, WC; Li, Y; Nan, YM; Ren, WG; Wang, RQ; Wu, WJ; Yu, J; Zhang, YG; Zhao, SX, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nan, YM | 1 |
| Kong, LB | 1 |
| Ren, WG | 1 |
| Wang, RQ | 1 |
| Du, JH | 1 |
| Li, WC | 1 |
| Zhao, SX | 1 |
| Zhang, YG | 1 |
| Wu, WJ | 1 |
| Di, HL | 1 |
| Li, Y | 1 |
| Yu, J | 1 |
| Ip, E | 1 |
| Farrell, G | 1 |
| Hall, P | 1 |
| Robertson, G | 1 |
| Leclercq, I | 1 |
| Toyama, T | 1 |
| Nakamura, H | 1 |
| Harano, Y | 1 |
| Yamauchi, N | 1 |
| Morita, A | 1 |
| Kirishima, T | 1 |
| Minami, M | 1 |
| Itoh, Y | 1 |
| Okanoue, T | 1 |
3 other studies available for pirinixic acid and Liver Cirrhosis
| Article | Year |
|---|---|
Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice.
Topics: Adiponectin; Animals; Anticholesteremic Agents; Carbon Tetrachloride; Cytokines; Ethanol; Gene Expre | 2013 |
Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
Topics: Animals; Cell Adhesion Molecules; Connective Tissue Growth Factor; Dietary Fats; Fatty Liver; Gene E | 2004 |
PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats.
Topics: Animals; Antioxidants; Blotting, Northern; Catalase; Densitometry; Fenofibrate; Fibrosis; Hydrogen P | 2004 |